C08B 35/02
Esters
C08B35/02 (Esters) appears on 16 US grants and 22 published applications in this corpus.
Search patents in C08B- Granted patents
- 16
- Published applications
- 22
- Assignees
- 8
- Inventors
- 22
- Latest grant
- 16 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 3 |
| 2014 | 1 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 4 |
| 2017 | 2 | 2 |
| 2018 | 1 | 0 |
| 2019 | 2 | 1 |
| 2020 | 2 | 1 |
| 2021 | 1 | 0 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Starch-derived clathrate-forming compositions16 Apr 2024US 11,959,114 B2
- Starch-derived clathrate-forming compositions23 May 2023US 11,655,491 B2
- Starch-derived clathrate-forming compositions10 May 2022US 11,326,195 B2
- Acylation process22 Jun 2021US 11,041,024 B2SOLVAY ACETOW GmbH
- Acylation process21 Apr 2020US 10,626,193 B2Rhodia Acetow GmbH
- Octenylsuccinylated waxy tapioca starches, emulsions including them and methods for making same26 Jun 2025US 2025/0204544 A1
- Starch-derived clathrate-forming compositions21 Jul 2022US 2022/0228182 A1
- Starch-derived clathrate-forming compositions21 Jul 2022US 2022/0228183 A1
- Starch-derived clathrate-forming compositions17 Dec 2020US 2020/0392548 A1
- Acylation Process30 May 2019US 2019/0161558 A1SOLVAY ACETOW GmbH
Most cited
By later US patents
- Modified starch material of biocompatible hemostasis11US 8,575,132 B22013
- Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate10US 7,115,576 B2Fresenius Kabi Deutschland GmbH · 2006
- Modified starch material of biocompatible hemostasis10US 8,912,168 B22014
- Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them6US 7,211,268 B2L'oreal · 2007
- Modified starch material of biocompatible hemostasis5US 9,533,005 B22017